Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for AXIN2-related attenuated familial adenomatous polyposis has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for AXIN2-related attenuated familial adenomatous polyposis.
60 publications have been identified in PubMed for AXIN2-related attenuated familial adenomatous polyposis. Research spans Basic Science / Preclinical (58%), Gene Therapy / Novel Therapeutics (10%), and Review / Meta-Analysis (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 35 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about AXIN2-related attenuated familial adenomatous polyposis
New treatment approaches |
6 |
10% |
Research summaries | 5 | 8% |
Disease patterns and progression | 5 | 8% |
Patient case studies | 4 | 7% |
Clinical study results | 3 | 5% |
Testing and diagnosis research | 2 | 3% |
Cao B (2026). [PMID: 41662882](https://pubmed.ncbi.nlm.nih.gov/41662882/). *Journal of controlled release : official journal of the Controlled Release Society*. [Gene Therapy / Novel Therapeutics]
Ferro A (2026). [PMID: 41827253](https://pubmed.ncbi.nlm.nih.gov/41827253/). *Journal of clinical medicine*. [Review / Meta-Analysis]
Breßer M (2026). [PMID: 41213597](https://pubmed.ncbi.nlm.nih.gov/41213597/). *Zentralblatt fur Chirurgie*. [Case Report / Case Series]
Kogami T (2026). [PMID: 41525292](https://pubmed.ncbi.nlm.nih.gov/41525292/). *Pathology international*. [Diagnostic / Biomarker]
Liu S (2026). [PMID: 41739974](https://pubmed.ncbi.nlm.nih.gov/41739974/). *ACS applied materials & interfaces*. [Case Report / Case Series]
Sun T (2026). [PMID: 41740338](https://pubmed.ncbi.nlm.nih.gov/41740338/). *International immunopharmacology*. [Basic Science / Preclinical]
Kanugovi A (2026). [PMID: 41505520](https://pubmed.ncbi.nlm.nih.gov/41505520/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]
Huang C (2026). [PMID: 41251878](https://pubmed.ncbi.nlm.nih.gov/41251878/). *Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association*. [Basic Science / Preclinical]
Yashaswini CN (2026). [PMID: 41564158](https://pubmed.ncbi.nlm.nih.gov/41564158/). *Science translational medicine*. [Basic Science / Preclinical]
Xu Q (2026). [PMID: 41478988](https://pubmed.ncbi.nlm.nih.gov/41478988/). *Methods in molecular biology (Clifton, N.J.)*. [Gene Therapy / Novel Therapeutics]